Posts Tagged ‘science jobs London’

Scientists develop environmentally friendly carbon catalysts

Thursday, June 7th, 2012

The Engineer has reported that Norwegian Scientists are developing carbon catalysts that could be used instead of precious metals to speed up chemical reactions.

The 3.2million EU-backed FREECATS (carbon nanostructures as metal free catalysts) project is aiming to develop environmentally friendly catalysts that can be used in fuel cells, water purification and the production of light olefins.  The scientists will attempt to build carbon structures on the atomic scale that are capable of binding or transforming substances in certain ways.

Catalysis is one of the major consumers of precious metals, such as platinum. However, platinum group metals are not usually found naturally in Europe therefore European countries rely on imports.  Bu using alternative catalysts Prof Magnus Rønning of Norwegian University of Science and Technology  said, ‘the European dependency on precious metals will ease and therefore the dependency on less stable countries to supply these’.

The three-year project commenced in April 2012 and the team hopes the first catalysts will be available by the end of this year. There are 9 European research institutions and technology enterprises are working on the project, which is being coordinated by the Norwegian University of Science and Technology.

Click here to see our latest engineering jobs

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

£250m new funding for life sciences

Tuesday, May 29th, 2012

As reported by the EuroBiotechNews,  approximately £250 million of new funding will go into life sciences across the country, a Government minister has announced.

Minister for Universities and Science, David Willetts, announced that £250M has been allocated for the first phase of several five year strategic investment programmes. This includes 26 strategic science programmes and 14 key national research capabilities, to be delivered by eight of the UK’s world-leading bioscience research institutes and their university partners. The process will be led by Britain’s Biotechnology and Biological Sciences Research Council (BBSRC). 

Universities and Science Minister David Willetts told MPs during Commons Business questions on Thursday that the investment was a “commitment” to Britain’s bioscience research base. Willetts also said: “This investment will sustain excellent science at some of the UK’s leading institutes and universities. This will drive growth, support highly skilled jobs and keep the UK at the very forefront of bioscience, with benefits ranging from healthcare to energy and global food security.”

Click here to see our latest life science jobs

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

 

GSK’s Votrient issued with a positive opinion from the European CHMP

Monday, May 28th, 2012

PharmPro reported that GlaxoSmithKline has announced that its Votrient (pazopanib) drug has been issued with a positive opinion by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

Votrient® (pazopanib) will be used in the  treatment of adult patients with selective subtypes of advanced Soft Tissue Sarcoma (STS) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

As part of its assessment, the CHMP reviewed safety and efficacy data from clinical studies, including one randomised, double-blind, placebo controlled, multi-centre Phase III study.

This is good news for those who have selective subtypes of advanced Soft Tissue Sarcoma.

Are you looking for a new science job? Click here to search our jobs in science now.

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

 

GSK acquire Cellzome for £61 million

Tuesday, May 15th, 2012

The Telegraph have reported that GSK  today, announced that it has entered an agreement to acquire Cellzome for £61 million in which they already own a 20pc stake.

Cellzome is the leader in the development and advancement of proteomics technologies. It currently has labs in Cambridge in the UK and Heidelberg in Germany. GSK currently own 19.98 % equity in the company but they will now assume full control of Cellzome. It will become part of GSK’s R&D organisation.

John Baldoni, senior vice-president of Platform & Technology Science at Glaxo, said: “The acquisition of Cellzome adds significantly to our scientific capabilities and capacity to characterise drug targets, and provides the opportunity to further enhance Glaxo’s ability to bring medicines to patients in a more effective manner.”

Looking for a job in science?

Click here to search our current jobs in science now.

Environmental Agency chairman supports gas extraction technique “fracking”

Tuesday, May 8th, 2012

Environmental Agency chairman supports gas extraction technique “fracking”The Telegraph has reported that the Environmental Agency boss has given his support to the controversial technique of gas extraction “Fracking”

The process of fracking (hydraulic fracturing) involves pumping water and chemicals into shale rock at high pressure to extract gas. Energy companies say the use of fracking will lead to cheaper supplies.

The chairman of the Environment Agency Lord Smith told BBC Radio 4′s Today programme that he would not stand in the way of fracking in the UK, as long as certain requirements were met, arguing that “it could be part of the answer” to the UK’s energy demands.

He also said “the source of a domestically available gas supply would, of course, be potentially very beneficial for our energy needs. It could provide energy security, which we don’t necessarily have when we import gas from abroad. It could be affordable,”

Click here to see our latest oil and gas industry jobs

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

NIH collaborate with Pfizer, AstraZeneca and Eli Lilly

Thursday, May 3rd, 2012

NIH collaborate with Pfizer, AstraZeneca and Eli LillyFierce Biotech reported that The National Institutes of Health today unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients.

NIH’s new National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly. The drug companies will offer up their data and investigators will have a chance to explore new uses, with a set of deal templates in place to help speed the process on 20 programs.

The investigators will have access to failed drugs to see if they can be repurposed for new uses.

Rod MacKenzie, group senior vice president, head of Pfizer PharmaTherapeutics Research and Development said “Pfizer has a rich history of partnering with the academic and public sectors to discover and develop innovative medicines…We believe that participating in this unique program, and making well researched molecules available to NIH’s broad network of researchers, is another important step in advancing a vibrant biomedical ecosystem.”

Are you looking for a new job in the pharmaceutical industry? Click here to see our latest pharmaceutical jobs in the UK

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

Nolato buys British pharmaceutical packaging company Cope Allman Jaycare

Thursday, April 12th, 2012

Plastics Today reported that Swedish injection molder Nolato has acquired Cope Allman Jaycare, a pharmaceutical packaging company based in the UK

Nolato have bought Cope Allman Jaycare for an initial SEK 179 million (USD $26 million) and a deferred consideration based on earnings up to and including the first quarter of 2014.

Cope Allman Jaycare has a history within pharmaceutical packaging dating back to 1958. The company has 270 employees at its plants in Portsmouth and Newcastle. They have annual sales of around SEK 270 million (USD $39 million), and its customers comprise of a number of international pharmaceutical companies.

Christer Wahlquist, president of Nolato Medical, in a press release said “Nolato already has a strong position in the Scandinavian pharmaceutical packaging market…….This acquisition gives us a local presence in the UK, which is an important part of the global pharmaceutical industry. It also opens doors with a large number of leading international pharmaceutical companies, which are existing customers of Cope Allman Jaycare.”

Click here to see our jobs in the packaging industry

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

Leicester science park plans to be approved tomorrow

Monday, April 2nd, 2012

This is Leicester reported that the long awaited development of the Leicester science park will receive a kick start as plans are set to be approved this week.

On Tuesday, Leicester City Council’s development control committee will discuss the development which planning officers have recommended for approval. The hope is that this park could provide 100’s of new jobs in the area, the scheme also includes a new supermarket to be built on land next to the science park site, which as it is understood will be run by Asda.

The first stage of the development is likely to cost £37 million but if planning consent is given tomorrow then the park could be finished by the end of the year. A city council planning spokesman said: “The proposal would have many significant positive regeneration impacts for the science park and the wider area.”

Click here to see our science industry jobs

Our Latest Science Jobs in the UK – 2nd of April 2012

Monday, April 2nd, 2012

Here is a list of our latest science jobs in the UK. Click on the links below to find out more and be the first to apply!

The North East and Scotland:

Microbiologist – North East

QC Manager – Pharmaceutical, NE England

Engineering Technician (Mechanical) – North East

Chemical Engineer – North East

Quality Control Technician-Pigments Dyes & Polymer

The South of the UK

Bioanalyst – Hertfordshire

Process Engineer, Pharmaceutical – Herts

Test Technician – Medical Devices, Cambridgeshire

Development Chemist – Cosmetics, Suffolk

Engineering Manager, Phamaceutical – Herts

Regulatory Affairs Officer – Pharma, Hampshire

The Midlands and the North West:

Medical Device Consultant

Raw Materials QC Analyst – North West

Operations Manager

Not quite what you’re looking for? Click here to register your CV with us today.

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

Senior R&D Scientist – North West

Monday, March 12th, 2012

Naynesh Mistry at CK Science is currently recruiting for a Senior R&D Scientist to join a leading manufacturer and supplier of clinical microbiology instrumentation in their product development team on a permanent basis in the North West

 

Job Summary:

This Senior R&D Scientist role will be to conduct research into and develop a wide range of new products for diagnostic microbiology with an emphasis on establishing novel molecular diagnostics.

 

Purpose/Objective:

As a Senior R&D Scientist you will carry out investigations related to both the improvement of existing products, and the improvement of manufacturing procedures and resolution of manufacturing problems, as well as working towards the achievement of recognition of significant new products through publication and presentation of external evaluations.

The primary focus of research will be the development of novel targets and probes for pathogenic micro-organisms with an emphasis on pathogens in human clinical disease.

The successful applicant will be expected to play a leading role in the development of a portfolio of molecular assays integrating a novel platform with forefront diagnostic assay. 

 

Qualifications and skills required:

The ideal candidate for this Senior R&D Scientist role will have a knowledge of nucleic amplification and extraction techniques is essential, combined with experience in conventional microbiological diagnostic methods.  Experience of primer design and bioinformatics software and databases would be advantageous

Ideally, candidates should have MSc or PhD in appropriate discipline or equivalent, as well as experience in commercial and/or academic research facilities, and be committed to continuous learning and professional development.

 

How to apply:

For more information or to apply for this Senior R&D Scientist role please contact Naynesh Mistry on 0114 2839956 or email nmistry@ckscience.co.uk. Please quote reference SH23878 in all correspondence.

 

Click here to see more R&D roles

Not quite what you are looking for? Register your CV with us now

Search for a job

Advanced search

20 years Download the CK Science iPhone App

Subscribe to our newsletter

Preview
Powered by FeedBlitz


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close